TrialPloS one2021

Comparison of biosimilar Tigerase and Pulmozyme in long-term symptomatic therapy of patients with cystic fibrosis and severe pulmonary impairment (subgroup analysis of a Phase III randomized open-label clinical trial (NCT04468100)).

Elena L Amelina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.